secwatch.observer — SEC 8-K summary
======================================

Issuer:     HilleVax, Inc. (—)
CIK:        0001888012
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0000950170-24-133668
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 2.05, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

HilleVax cuts 70% of workforce (28 employees) and three officers depart; expects $6.1M severance charges
--------------------------------------------------------------------------------

- Workforce reduction of 28 employees (approx. 70% of workforce) effective Dec 4, 2024; substantially complete by end of Jan 2025.
- Estimated charges of ~$6.1M for severance, benefits, and termination costs; majority recognized in Q4 2024.
- COO Sean McLoughlin, CMO Astrid Borkowski, and CBO Aditya Kohli cease officer roles Dec 19; McLoughlin and Kohli become consultants, Borkowski non-executive employee.
- Company to continue evaluating norovirus vaccine candidates and exploring business development and strategic alternatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1888012/000095017024133668/0000950170-24-133668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1888012/000095017024133668/hlvx-20241204.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-133668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer